Prognostic Role of Hypoxic Inducible Factor Expression in Non-small Cell Lung Cancer: A Meta-analysis
Authors:
- Hua-Jun LuHLHua-Jun Lu
- Fei-Fei NaFNFei-Fei Na
- Lei DengLDLei Deng
- Jian-Xin XueJXJian-Xin Xue
- Jing-Wen WangJWJing-Wen Wang
- Yu-Qing WangYWYu-Qing Wang
- Qiao-Ling LiQLQiao-Ling Li
- You LuYLYou Lu
Open Access
- 30 June 2013
- journal article
- research article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 14 (6) , 3607-3612
Abstract
Prognostic Role of Hypoxic Inducible Factor Expression in Non-small Cell Lung Cancer: A Meta-analysis Hypoxic inducible factors;prognosis;non-small cell lung cancer;meta-analysis; Introduction: Reported prognostic roles of hypoxic inducible factor (HIF) expression in non-small cell lung cancer (NSCLC) have varied. This meta-analysis aimed to examine the relationship between HIF expression and clinical outcome in NSCLC patients. Methods: PubMed were used to identify relevant literature with the last report up to December $20^{th}$, 2012. After careful review, survival data were collected from eligible studies. We completed the meta-analysis using Stata statistical software (Version 11) and combined hazard ratio (HR) for overall survival (OS). Subgroup specificity, heterogeneity and publication bias were also assessed. All of the results were verified by two persons to ensure accuracy. Results: Eight studies were finally stepped into this meta-analysis in which seven had available data for HIF-$1{\alpha}$ and three for HIF-$2{\alpha}$. Combined HRs suggested that higher expression of $HIF1{\alpha}$ had a negative impact on NSCLC patient survival (HR=1.50; 95%CI=1.07-2.10; p=0.019). The expression of HIF-$2{\alpha}$ was also relative to a poorer survival (HR=2.02; 95%CI=1.47-2.77; p=0.000). No bias existed in either of the two groups. Conclusion: This study suggests that elevations of HIF-$1{\alpha}$ and HIF-$2{\alpha}$ expression are both associated with poor outcome for patients with NSCLC. The data support further and high quality investigation of HIF expression for predicting poor outcome in patients with NSCLC.
Keywords
This publication has 39 references indexed in Scilit:
- Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients with Esophageal Cancer: A Systematic Review and Meta-analysisCancer Epidemiology, Biomarkers & Prevention, 2012
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and ElaborationPLOS Medicine, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The International Association for the Study of Lung Cancer Staging Project: Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung CancerJournal of Thoracic Oncology, 2009
- A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growthMolecular Cancer Therapeutics, 2008
- Random-effects model for meta-analysis of clinical trials: An updateContemporary Clinical Trials, 2007
- Prognostic significance of HIF-2α/EPAS1 expression in hepatocellular carcinomaWorld Journal of Gastroenterology, 2007
- Hypoxia‐inducible factor‐1α in non small cell lung cancer: Relation to growth factor, protease and apoptosis pathwaysInternational Journal of Cancer, 2004
- Hypoxia-inducible factors 1?? and 2?? are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skinMelanoma Research, 2003
- Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survivalBritish Journal of Cancer, 2001